Connection | Profiles RNS

Search Result Details

Back to Search Results

This page shows the details of why an item matched the keywords from your search.

Search Results

Garassino, Marina Chiara

One or more keywords matched the following items that are connected to Garassino, Marina Chiara

Item Type	Name
Concept	Immunotherapy
Academic Article	Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer.
Academic Article	DiM: Prognostic Score for Second- or Further-line Immunotherapy in Advanced Non-Small-Cell Lung Cancer: An External Validation.
Academic Article	The evolving landscape of criteria for evaluating tumor response in the era of cancer immunotherapy: From Karnofsky to iRECIST.
Academic Article	Maintenance or consolidation therapy in small-cell lung cancer: a systematic review and meta-analysis.
Academic Article	Integrating clinical and biological prognostic biomarkers in patients with advanced NSCLC treated with immunotherapy: the DEMo score system.
Academic Article	Nivolumab and brain metastases in patients with advanced non-squamous non-small cell lung cancer.
Academic Article	Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Academic Article	Choosing the Best Chemotherapy Agent to Boost Immune Checkpoint Inhibition Activity.
Academic Article	Association between antibiotic-immunotherapy exposure ratio and outcome in metastatic non small cell lung cancer.
Academic Article	Characterization of patients with metastatic non-small-cell lung cancer obtaining long-term benefit from immunotherapy.
Academic Article	Immune checkpoint inhibitors and chemotherapy in first-line NSCLC: a meta-analysis.
Academic Article	Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?
Academic Article	Efficacy and safety of immunotherapy in elderly patients with non-small cell lung cancer.
Academic Article	Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases.
Academic Article	Immune Checkpoint Blockade: A New Era for Non-Small Cell Lung Cancer.
Academic Article	Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study.
Academic Article	Immunotherapy in advanced Non-Small Cell Lung Cancer patients with poor performance status: The role of clinical-pathological variables and inflammatory biomarkers.
Academic Article	Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy.
Academic Article	Chemotherapy in non-small cell lung cancer patients after prior immunotherapy: The multicenter retrospective CLARITY study.
Academic Article	Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don't) know.
Academic Article	Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out.
Academic Article	Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
Academic Article	Relationship Between Programmed Death Receptor-Ligand 1 Expression and Response to Checkpoint Inhibitor Immunotherapy in Pulmonary Sarcomatoid Carcinoma: A Pooled Analysis.
Academic Article	Antiangiogenic therapy for patients with aggressive or refractory advanced non-small cell lung cancer in the second-line setting.
Academic Article	Outcomes from salvage chemotherapy or pembrolizumab beyond progression with or without local ablative therapies for advanced non-small cell lung cancers with PD-L1 =50% who progress on first-line immunotherapy: real-world data from a European cohort.
Academic Article	Myeloid cell heterogeneity in lung cancer: implication for immunotherapy.
Academic Article	Is the chemotherapy era in advanced non-small cell lung cancer really over? Maybe not yet.
Academic Article	EPSILoN: A Prognostic Score for Immunotherapy in Advanced Non-Small-Cell Lung Cancer: A Validation Cohort.
Academic Article	Immunotherapy: a new standard of care in thoracic malignancies? A summary of the European Respiratory Society research seminar of the Thoracic Oncology Assembly.
Academic Article	Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy.
Academic Article	Novel patterns of progression upon immunotherapy in other thoracic malignancies and uncommon populations.
Academic Article	Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
Academic Article	Prognostic role of neutrophil-to-lymphocyte ratio and EPSILoN score in advanced non-small-cell lung cancer patients treated with first-line chemo-immunotherapy.
Academic Article	Circulating Fatty Acid Profile as a Biomarker for Immunotherapy in Advanced Non-Small Cell Lung Cancer.
Academic Article	Is hyperprogressive disease a specific phenomenom of immunotherapy?
Academic Article	Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
Academic Article	The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy.
Academic Article	What is the ideal endpoint in early-stage immunotherapy neoadjuvant trials in lung cancer?
Academic Article	Real-World Treatment Patterns and Outcomes of First-Line Immunotherapy Among Patients With Advanced Nonsquamous NSCLC Harboring BRAF, MET, or HER2 Alterations.
Academic Article	Exploring the Role of Immunotherapy-Based Treatments for Advanced Non-Small-Cell Lung Cancer With Novel Driver Alterations.
Academic Article	Face to face among different chemo-immunotherapy combinations in the first line treatment of patients with advanced non-small cell lung cancer: Results of an international expert panel meeting by the italian association of thoracic oncology (AIOT).
Academic Article	Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.
Academic Article	Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study.
Academic Article	Precision Immunotherapy for STK11/KEAP1-Mutant NSCLC.

Search Criteria

Immunotherapy